Back

Single pill treatment in daily practice is associated with improved clinical outcomes and all-cause mortality in cardiovascular diseases: results from the START project

26 August 2022 (11:15 - 11:40)
Organised by:
Congress Presentation Part of: Cardiovascular risk assessment 1 Cardiovascular Risk Assessment ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Burkhard Weisser

Christian-Albrechts-University Kiel, Kiel (Germany)

3 More presentations in this session

Presentation thumbnail
The workload-indexed blood pressure response predicts cardiovascular events and all-cause mortality in coronary artery disease
Doctor B. Braganca (Porto, PT)
Abstract Slides
Presentation thumbnail
Evaluation of cardiovascular risk and LDL-cholesterol targets by cardiologists using the case-vignette method
Slides
Presentation thumbnail
Prevalence of standard modifiable cardiovascular risk factors in patients with ST segment elevation myocardial infarction and its relation with outcomes
Doctor M. Bergami (Bologna, IT)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular risk assessment 1

The Event

Event poster

ESC Congress 2022

26 August 2022 11:15 CET
You may be interested in
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Webinar
Update on dyslipidaemia management: focus on risk estimation and lipoprotein(a)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources